Table 3.
Patient No. | PC20 (mg/ml)
|
PC20 Ratio, 24 μg:12 μg | Fold Change in PC20 from Screening
|
||
---|---|---|---|---|---|
12 μg | 24 μg | 12 μg | 24 μg | ||
3 | 1.29 | 2.17 | 1.68 | 2.10 | 3.60 |
7 | 27.75 | 64.00 | 2.30 | 44.80 | 103.00 |
12 | 2.03 | 7.71 | 3.80 | 4.80 | 18.30 |
13 | 43.30 | 64.00 | 1.48 | 9.21 | 13.62 |
20 | 34.80 | 52.50 | 1.50 | 57.10 | 86.10 |
21 | 3.19 | 8.40 | 2.60 | 2.30 | 6.10 |
29 | 1.47 | 1.57 | 1.07 | 4.30 | 4.60 |
30 | 30.75 | 64.00 | 2.08 | 13.50 | 28.20 |
31 | 18.00 | 64.00 | 3.60 | 3.80 | 13.62 |
36 | 1.24 | 4.30 | 3.46 | 1.00 | 3.50 |
| |||||
Geometric Mean (95% confidence interval) | |||||
| |||||
7 (2–22) | 16 (5–45)a | 2.2 (1.6–3.0) | 6 (2–16) | 14 (6–33) |
PC20 = provocational concentration of methacholine required to decrease forced expiratory volume in 1 second by 20%.
p≤0.001.